Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | VP, General Counsel & Corp Sec | January 08, 2025 | January 10, 2025 |
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | SVP, Gen. Counsel & Secretary | May 31, 2022 | June 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date January 08, 2025 · Filed January 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,506 |
Ending reported balance
After 2025-01-08 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-01-08 · Exercise / conversion · Acquired 1,140 · Balance 2,017 Row 2 · 2025-01-08 · Exercise / conversion · Acquired 2,352 · Balance 4,369 Row 3 · 2025-01-08 · Tax withholding · Disposed 579 · Balance 3,790 Row 4 · 2025-01-08 · Tax withholding · Disposed 1,284 · Balance 2,506 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-12-13 | Direct | 2,272 |
Reported balance
After 2025-01-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-01-08 · Exercise / conversion · Disposed 1,140 · Balance 2,272 F1: This award vests 25%/year over 4 years - 1,136 shares on 1/8/2024, 1,140 shares on 1/8/2025, 1,136 shares on 1/8/2026, 1,136 shares on 1/8/2027 - subject to continued service. F2: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2033-12-12 | Direct | 7,052 |
Reported balance
After 2025-01-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-01-08 · Exercise / conversion · Disposed 2,352 · Balance 7,052 F3: This award vests 25%/year over 4 years - 2,352 shares on 1/8/2025, 2,352 shares on 1/8/2026, 2,348 shares on 1/8/2027, 2,352 shares on 1/8/2028 - subject to continued service. F2: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024. |
Filing footnotes · ownership attribution and instrument terms
F1: This award vests 25%/year over 4 years - 1,136 shares on 1/8/2024, 1,140 shares on 1/8/2025, 1,136 shares on 1/8/2026, 1,136 shares on 1/8/2027 - subject to continued service.
F2: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024.
F3: This award vests 25%/year over 4 years - 2,352 shares on 1/8/2025, 2,352 shares on 1/8/2026, 2,348 shares on 1/8/2027, 2,352 shares on 1/8/2028 - subject to continued service.
STANDARD BIOTOOLS INC.
Report date May 31, 2022 · Filed June 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,480 |
Reported balance
After 2022-05-31 transaction · row 1
1 source rowRow 1 · 2022-05-31 · Grant · Acquired 3,341 · Balance 100,480 F1: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2025 Filed Jan 10, 2025 21:10 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 2,352 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000301 · primarydocument.xml · derivative · entry 6 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,052 Underlying: Common Stock · 2,352 shares Expires 2033-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This award vests 25%/year over 4 years - 2,352 shares on 1/8/2025, 2,352 shares on 1/8/2026, 2,348 shares on 1/8/2027, 2,352 shares on 1/8/2028 - subject to continued service. F2 · balance_after: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:10 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 1,140 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000301 · primarydocument.xml · derivative · entry 5 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,272 Underlying: Common Stock · 1,140 shares Expires 2032-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award vests 25%/year over 4 years - 1,136 shares on 1/8/2024, 1,140 shares on 1/8/2025, 1,136 shares on 1/8/2026, 1,136 shares on 1/8/2027 - subject to continued service. F2 · balance_after: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:10 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 1,284 | $91.88 | $117,973.92 |
DisclosureSEC source: 0001562180-25-000301 · primarydocument.xml · nonDerivative · entry 4 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,506 Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:10 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 579 | $91.88 | $53,198.52 |
DisclosureSEC source: 0001562180-25-000301 · primarydocument.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,790 Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:10 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 2,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000301 · primarydocument.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:10 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 1,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000301 · primarydocument.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 23:12 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 8,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008376 · primarydocument.xml · derivative · entry 2 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,578 Underlying: Common Stock · 8,578 shares Expires 2034-12-10 F4 · derivative.exercise_date: 25%/year over 4 years - Jan 8 vest date beginning on 08-Jan-2025 F5 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2024 Filed Jan 11, 2024 00:11 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 284 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000422 · primarydocument.xml · derivative · entry 3 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853 Underlying: Common Stock · 284 shares Expires 2032-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25%/year over 4 years - Jan 8 vest date beginning on 08-Jan-2023 Read SEC document |
| January 08, 2024 Filed Jan 11, 2024 00:11 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 116 | $373.57 | $43,334.12 |
DisclosureSEC source: 0001562180-24-000422 · primarydocument.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208.959 Read SEC document |
| January 08, 2024 Filed Jan 11, 2024 00:11 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 284 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000422 · primarydocument.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324.959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2024 Filed Feb 15, 2024 21:57 UTC Amendment | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 157 | $373.57 | $58,650.49 |
DisclosureSEC source: 0001562180-24-001328 · primarydocument.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167.959 F1 · shares: Reflects corrected number of shares withheld to cover taxes on release of RSUs on January 8, 2024. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 00:11 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 2,351 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-008383 · primarydocument.xml · derivative · entry 2 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires 2033-12-12 F2 · derivative.exercise_date: 25%/year over 4 years - Jan 8 vest date beginning on 08-Jan-2024 Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 22:51 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantStock Options (Right to Buy) · Derivative | 3,635 | $0.00 Strike: $329.83 | $0.00 |
DisclosureSEC source: 0001562180-22-008290 · primarydocument.xml · derivative · entry 2 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,635 Underlying: Common Stock · 3,635 shares Expires 2032-12-13 F2 · derivative.exercise_date: 25%/year over 4 years - Anniversary vesting Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 22:51 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 1,137 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008290 · primarydocument.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137 Underlying: Common Stock · 1,137 shares Expires 2032-12-13 F1 · derivative.exercise_date: 25%/year over 4 years - beginning Jan 8 2024 Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:03 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantStock Options (Right to Buy) · Derivative | 3,159 | $0.00 Strike: $300.12 | $0.00 |
DisclosureSEC source: 0001562180-22-006443 · primarydocument.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · VP, General Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,159 Underlying: Common Stock · 3,159 shares Expires 2032-09-01 F1 · derivative.exercise_date: 9-1-2022 NQ - 25%/year over 4 years - Anniversary vesting beginning on 9-1-2023 Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 22:01 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 3,341 | $1.61 | $5,368.99 |
DisclosureSEC source: 0001162194-22-000065 · wf-form4_165429367255247.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,480 F1 · kind: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 9,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · derivative · entry 7 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,541 Underlying: Common Stock · 9,846 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · derivative · entry 6 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. F3 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · derivative · entry 5 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 4,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F2 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Tax withholdingCommon Stock | 14,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 4 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,139 Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 9,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:16 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 4,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000016 · wf-form4_164574104236642.xml · derivative · entry 3 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,563 Underlying: Common Stock · 4,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 2,269 | $3.62 | $8,213.78 |
DisclosureSEC source: 0001162194-22-000016 · wf-form4_164574104236642.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,391 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000016 · wf-form4_164574104236642.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2022 Filed Jan 26, 2022 00:37 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000006 · wf-form4_164315741348627.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." F2 · derivative.expiration_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:45 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000095 · wf-form4_163779749250548.xml · derivative · entry 3 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,625 Underlying: Common Stock · 4,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:45 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 2,014 | $4.49 | $9,042.86 |
DisclosureSEC source: 0001162194-21-000095 · wf-form4_163779749250548.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,235 Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:45 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000095 · wf-form4_163779749250548.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000078 · wf-form4_162984653970259.xml · derivative · entry 3 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,688 Underlying: Common Stock · 4,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 2,013 | $6.53 | $13,144.89 |
DisclosureSEC source: 0001162194-21-000078 · wf-form4_162984653970259.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,186 Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000078 · wf-form4_162984653970259.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,057 shares purchased on May 28, 2021 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000044 · wf-form4_162188691915220.xml · derivative · entry 5 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. F3 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000044 · wf-form4_162188691915220.xml · derivative · entry 4 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,750 Underlying: Common Stock · 16,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 22,838 | $5.52 | $126,065.76 |
DisclosureSEC source: 0001162194-21-000044 · wf-form4_162188691915220.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,080 Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000044 · wf-form4_162188691915220.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000044 · wf-form4_162188691915220.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 22:31 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 39,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000030 · wf-form4_161913063343300.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,387 Underlying: Common Stock · 39,387 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 23, 2020 Filed May 26, 2020 13:31 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000061 · wf-form4_159049987388141.xml · derivative · entry 2 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 23, 2020 Filed May 26, 2020 13:31 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000061 · wf-form4_159049987388141.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023. F2 · derivative.expiration_date: Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 8,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · derivative · entry 9 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,776 Underlying: Common Stock · 8,258 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F6 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 33,034 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F6 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 33,034 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · derivative · entry 8 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,259 Underlying: Common Stock · 2,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · derivative · entry 7 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,242 Underlying: Common Stock · 1,975 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · derivative · entry 6 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Underlying: Common Stock · 675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units vesting as to 14/48th of the total number of shares on August 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units vesting as to 14/48th of the total number of shares on August 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 7,354 | $3.75 | $27,577.50 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · nonDerivative · entry 5 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,668 Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 8,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · nonDerivative · entry 4 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000011 · wf-form4_158258195585018.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,864 shares purchased on November 29, 2019 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.